Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
- PMID: 6460831
- PMCID: PMC2186638
- DOI: 10.1084/jem.155.4.1063
Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells
Abstract
On the basis of preceding studies showing that tumor-induced, T cell-mediated immunosuppression serves as an obstacle to adoptive immunotherapy of the Meth A fibrosarcoma, it was predicted that cyclophosphamide treatment of tumor bearers would remove this obstacle and allow passively transferred immune T cells to cause tumor regression. It was found that infusion of immune spleen cells alone had no effect on tumor growth, and cyclophosphamide alone caused a temporary halt in tumor progression. In contrast, combination therapy consisting of intravenous injection of 100 mg/kg of cyclophosphamide followed 1 h later by intravenous infusion of tumor-immune spleen cells caused small, as well as large tumors, to completely and permanently regress. Tumor regression caused by combination therapy was completely inhibited by intravenous infusion of splenic T cells from donors with established tumors, but not by spleen cells from normal donors. These suppressor T cells were eliminated from the spleen by treating the tumor-bearing donors with 100 mg/kg of cyclophosphamide. Immune T cells, in contrast, were resistant to this dose of cyclophosphamide. These results show that failure of intravenously-infused, tumor-sensitized T cells to cause regression of the Meth A fibrosarcoma growing in its syngeneic or semi-syngeneic host is caused by the presence of a tumor-induced population of cyclophosphamide-sensitive suppressor T cells.
Similar articles
-
T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.J Exp Med. 1981 Oct 1;154(4):1033-42. doi: 10.1084/jem.154.4.1033. J Exp Med. 1981. PMID: 6457075 Free PMC article.
-
Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.Acta Med Okayama. 1988 Dec;42(6):301-10. doi: 10.18926/AMO/31006. Acta Med Okayama. 1988. PMID: 3266420
-
Cyclophosphamide (Cy)-facilitated adoptive immunotherapy of a Cy-resistant tumour. Evidence that Cy permits the expression of adoptive T-cell mediated immunity by removing suppressor T cells rather than by reducing tumour burden.Immunology. 1988 Sep;65(1):87-92. Immunology. 1988. PMID: 2972604 Free PMC article.
-
Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells.Cancer Immunol Immunother. 1984;16(3):175-81. doi: 10.1007/BF00205425. Cancer Immunol Immunother. 1984. PMID: 6231095 Free PMC article.
-
The immunological network at the site of tumor rejection.Biochim Biophys Acta. 1986 Aug 5;865(1):1-11. doi: 10.1016/0304-419x(86)90009-0. Biochim Biophys Acta. 1986. PMID: 2942190 Review.
Cited by
-
Trial Watch: Adoptive cell transfer immunotherapy.Oncoimmunology. 2012 May 1;1(3):306-315. doi: 10.4161/onci.19549. Oncoimmunology. 2012. PMID: 22737606 Free PMC article.
-
Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells.Cancer Immunol Immunother. 1991;33(3):146-52. doi: 10.1007/BF01756134. Cancer Immunol Immunother. 1991. PMID: 1675153 Free PMC article.
-
Antitumor effect of interleukin-1 beta in the double grafted tumor system.Jpn J Cancer Res. 1989 Jun;80(6):570-6. doi: 10.1111/j.1349-7006.1989.tb01677.x. Jpn J Cancer Res. 1989. PMID: 2503477 Free PMC article.
-
Peripheral Tolerization of Effector and Memory T Cells: Implications for Autoimmunity and Tumor-Immunity.Curr Immunol Rev. 2005 Jan 1;1(1):21-28. doi: 10.2174/1573395052952879. Curr Immunol Rev. 2005. PMID: 20411047 Free PMC article.
-
Therapeutic cancer vaccines in combination with conventional therapy.J Biomed Biotechnol. 2010;2010:237623. doi: 10.1155/2010/237623. Epub 2010 Jun 29. J Biomed Biotechnol. 2010. PMID: 20617155 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources